Lenvatinib-TACE Improves Local Control in Hepatocellular Carcinoma



Hepatocellular carcinoma (HCC), the most common primary liver cancer with poor prognosis, is treated with TACE, but lacks promising pretreatment biomarkers despite CR being a surrogate for survival.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our